Robert J. Weinstock, MD
Private Practice
The Eye Institute of West Florida
Largo, FL
William F. Wiley, MD
Medical Director
Cleveland Eye Clinic
Division of Midwest Vision Partners
Cleveland, OH
DISCLOSURE POLICY
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent financial relationships relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all financial relationships prior to this educational activity.
The following faculty/staff members have the following financial relationships with ineligible companies.
Robert J. Weinstock, MD, has a financial agreement or affiliation with the following ineligible companies in the form of Consultant: Bausch & Lomb, Alcon, J&J Vision, LENSAR, Trefoil, BVI, Eye Point Pharmaceuticals, Beyeonics, Visus, Elios Vision, and ViaLase. Grant/Research Support: RxSight, Visus, SpyGlass Pharma, and LENSAR. Shareholder: RxSight, RPS, EyeSafe, Tissuetech, ViaLase, Visus Therapeutics, Elios Vision, Alchemy Vision Project, and Omega Ophthalmics LLC. Speaker’s Bureau: LENSAR, Bausch + Lomb, and Johnson & Jonson
William F. Wiley, MD, has a financial agreement or affiliation with the following ineligible companies in the form of Consultant: AcuFocus, Allergan, Alcon, Bausch + Lomb, Carl Zeiss Meditic, Johnson & Johnson, Dompe, Imprimis, and RxSight. Grant/Research Support: AcuFocus. Speaker’s Bureau: New World Medical and Carl Zeiss Meditec.
Akaanksh Shetty, MD has no financial relationships with ineligible companies
Allison Shuren, JD, has no financial relationships with ineligible companies
Albert Castillo, has no financial relationships with ineligible companies.
Arjan Hura, MD has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Alcon, Allergan, B+L/AcuFocus, BVI, Rayner, Twenty Twenty Therapeutics, Tarsus, Visus, and Carl Zeiss Meditec. Grant / Research Support: Alcon. Speakers Bureau: Alcon
Blake Williamson, MD has a financial agreement or affiliation with the following ineligible companies in the form of Consultant: Allergan, AbbVie, Carl Zeiss Meditec, Johnson & Johnson Vision, New World Medical, Quidel Corporation, and Sight Sciences. Speaker’s Bureau: Allergan, AbbVie, Glaukos, and New World Medical.
Caroline Watson, MD had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Alcon, Biotissue, Bausch + Lomb, Corza medical, Johnson & Johnson, Dompe, BVI/Beyeonics, Visus Therapeutics, Tarsus, Carl Zeiss Meditec, Ocuphire, Lumenis, Allergan, MST, and RxSight. Speaker’s Bureau: Alcon, Biotissue, Bausch + Lomb, and Tarsus
Cathleen McCabe, MD had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Alcon, Bausch & Lomb, Allergan, Novartis, Ivantis, Zeiss, Omeros, Ocular Therapeutix, EyePoint Pharma, Sight sciences, Science Based Health, Imprimis, Dompe, Tarsus, Visus, Orasis, Quidel, Eyevance, Lensar, I star, Medical, Easee, and Engage Technologies Spy Glass. Grant / Research Support: Alcon, Ivantis, Glaukos, Sun Pharmaceuticals, Orasis, Ocular Therapeutix and Ora. Shareholder: Engage Technologies
Chris Moore has no financial relationships with ineligible companies
Cristos Ifantides, MD has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant and Advisory Board: AbbVie, Ace Vision Group, Alcon, Bausch + Lomb, BVI, Centricity Vision, Hu-Med Technologies, Johnson & Johnson, Spect Inc, Tarsus Pharmaceuticals, Trefoil, Visus Therapeutics, Carl Zeiss Meditec, and LensAR. Speaker’s Bureau: Centricity Vision. Grant/Research Support: Bausch + Lomb, Centricity Vision, Johnson & Johnson, and New World Medical. Shareholder: Ace Vision Group, Hu-Med Technologies, iSense Therapeutics, Spect, Inc, and Tarsus Pharmaceuticals. Patent: Hu-Med Technologies and Tarsus Pharmaceuticals
Dan Chambers has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: DCOM Services and RxSight
Dan Welch, MD has no financial relationships with ineligible companies
David Stephens, MD has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant and Speaker’s Bureau: AbbVie/Allergan, Alcon, Glaukos, and RxSight.
Denise Visco, MD has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Bausch + Lomb, Cassini, LENSAR, Oyster Point Pharma, Rayner, and Carl Zeiss Meditec. Grant/Research Support: Lensar and Oyster Point Pharma. Speaker’s Bureau: Lensar, Rayner, and Carl Zeiss Meditec.
Frank Bucci, MD has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Acufocus, Glaukos, Johnson & Johnson, and RxSight. Shareholder: PRN
Gary Wortz, MD has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Alcon, Bausch + Lomb, Carl Zeiss Meditec, Dompé, Johnson & Johnson Vision, Lensar, Ocular Science & Ocuphire, Tarsus, TearClear. Stock/Shareholder: Arcuate Innovations, Johnson & Johnson, Ocular Science and Omega Ophthalmics. Speaker: Lensar. Royalties: Science Based Health, Dompé, Lensar, Ocular Science, Alcon and Carl Zeiss Meditec.
Huda Sheheitli, MD has no financial relationships with ineligible companies
I. Paul Singh, MD has a financial agreement or affiliation with the following ineligible companies in the form of Consultant: AbbVie, Aerie, Allergan, Alcon, Bausch + Lomb, Carl Zeiss Meditec, Elios, Ellex, Glaukos, Ivantis, MMD, New World Medical, Novartis, Ocular Therapeutix, Oyster Point Pharma, Reichert, Inc, Santen, and Sight Sciences. Speaker: AbbVie, New World Medical, Aerie, Allergan, Alcon, Bausch + Lomb, Beaver-Visitec International, Inc., Carl Zeiss Meditec, Ivantis, Ocular Therapeutix, and Sight Sciences. Shareholder: CoFI.
Ivan Mac, MD has a financial agreement or affiliation with the following ineligible companies in the form of Consultant: Alcon, Trukera Medical and Johnson & Johnson. Advisory Board: NovaBay, Tarsus, and Bruder health. Speaker’s Bureau: Alcon, Johnson & Johnson, NovaBay, Bruder health and Trukera Medical. Shareholder: Tarsus and Visionary Venture Group
Jack Chapman, MD has a financial agreement or affiliation with the following ineligible companies in the form of Consultant: Alcon, Lensar, Sun Pharmaceuticals, and Trukera Medical. Speaker’s Bureau: Alcon, Lensar, Sun Pharmaceuticals, Tarsus and Trukera Medical. Shareholder: Visiox Pharma
James Katz, MD has a financial agreement or affiliation with the following ineligible companies in the form of Consultant: Alcon, Carl Zeiss Meditec, Novartis, Bausch + Lomb, Sight Sciences and Glaukos. Speaker’s Bureau: AbbVie and Allergan. Shareholder: Glaukos, Mati, and Olleyes
James Lehman, MD has a financial agreement or affiliation with the following ineligible companies in the form of Consultant: Johnson & Johnson, RxSight, and Lensar. Grant/Research Support: Johnson & Johnson, RxSight, Lensar, and Glaukos. Shareholder: RxSight.
Jim Loden, MD has a financial agreement or affiliation with the following ineligible companies in the form of Consultant and Speaker’s Bureau: Johnson & Johnson
Joaquin De Rojas, MD has a financial agreement or affiliation with the following ineligible companies in the form of Consultant: Lensar, Carl Zeiss Meditec, Johnson & Johnson, Oculus Biologics, and Sun Pharmaceuticals. Grant/Research Support: Johnson & Johnson. Speaker’s Bureau: Johnson & Johnson and Sun Pharmaceuticals.
John Doane, MD has a financial agreement or affiliation with the following ineligible companies in the form of Consultant: Carl Zeiss Meditec Speaker’s Bureau: Carl Zeiss Meditec
Karyn Jones
Kiper Nelson, MD has no financial relationships with ineligible companies
Kirk Labor, MD has a financial agreement or affiliation with the following ineligible companies in the form of Consultant: Rayner
Kirk Mack has no financial relationships with ineligible companies
Luke Rebenitsch, MD has a financial agreement or affiliation with the following ineligible companies in the form of Consultant: RxSight, Carl Zeiss Meditec, Staar Surgical, and iOR Partners. Shareholder: OSRx Pharmaceuticals
J. Morgan Micheletti, MD has a financial agreement or affiliation with the following ineligible companies in the form of Consultant: Alcon, AbbVie, Bausch + Lomb, and Carl Zeiss Meditec Speaker’s Bureau: Alcon, New World Medical, and Beaver-Visitec International.
Mary Davidian, MD has a financial agreement or affiliation with the following ineligible companies in the form of Consultant and Speaker’s Bureau: Dompe and BioTissue.
Mary Pat Johnson has no financial relationships with ineligible companies
Matt Owens has no financial relationships with ineligible companies
Mike Romansky, JD has no financial relationships with ineligible companies
Mitchell Jackson, MD has a financial agreement or affiliation with the following ineligible companies in the form of Consultant: Allergan/AbbVie, Bausch + Lomb, RxSight, Trukera, Carl Zeiss Meditec, Oyster Point Pharma/Viatris, Tarsus and Johnson & Johnson. Speaker’s Bureau: Bausch + Lomb, RxSight, Carl Zeiss Meditec, and Tarsus.
P. Dee Stephenson, MD has a financial agreement or affiliation with the following ineligible companies in the form of Consultant: Alcon, Allergan, Atia, Bausch + Lomb, Bruder, Cassini, Bompe, ESWIN, Gaudion Health Services, Lensar, Rayner, Tarsus, Viatris, Visiox, TopCon Medical Systems, and Carl Zeiss Meditec. Speaker’s Bureau: Sun Pharmaceuticals, Carl Zeiss Meditec, Alcon, Allergan, Atia, Ocular Therapeutix, Bausch + Lomb, Bruder, Cassini, ESWIN, Guardion Health Services, Rayner, Sight Sciences, and Viatris. Grant/Research Support: Bausch + Lomb, Cassini, and Dompe. Shareholder: Visiox
Parag Majmudar, MD has a financial agreement or affiliation with the following ineligible companies in the form of Consultant: Alcon, Bausch + Lomb, and Carl Zeiss Meditec. Speaker’s Bureau: Carl Zeiss Meditec, Sun Pharmaceuticals, Bausch + Lomb, and Dompe.
Rachel Schneider, MD has a financial agreement or affiliation with the following ineligible companies in the form of Consultant: Lensar and BVI.
Regina Boore, MS, RN, CASC has no financial relationships with ineligible companies
Scott LaBorwit, MD has a financial agreement or affiliation with the following ineligible companies in the form of Consultant: Alcon, Sight Sciences. Speaker’s Bureau: Alson and Lensar
Shaina Kumar, MD has no financial relationships with ineligible companies
Shalesh Kaushal, MD, PhD has no financial relationships with ineligible companies
Shamik Bafna, MD has a financial agreement or affiliation with the following ineligible companies in the form of Consultant: Alcon, Johnson & Johnson, Bausch & Lomb, Beaver Visitec, Carl Zeiss Meditec, and Sight Sciences. Grant/Research Support: RxSight, Rayner, Carl Zeiss Meditec, and Alcon.
Sheri Rowen, MD has a financial agreement or affiliation with the following ineligible companies in the form of Consultant: Alcon, Ace Vision Group, AbbVie, Atia Vision, Bausch + Lomb, Johnson & Johnson, Ocuterra, Orasis, Carl Zeiss Meditec, RxSight, Sight Science, Stuart, Tarsus, Thea, Visus, and Viatris. Speaker’s Bureau: Alcon, Ace Vision Group, Atia Vision, Bausch + Lomb, RxSight, and SBH.
Steven Dell, MD has a financial agreement or affiliation with the following ineligible companies in the form of Consultant: Johnson and Johnson, Bausch + Lomb, RxSight, Novartis, Allergan, LENZ Therapeutics, Ocular Therapeutix, Optical Express, Tracey Technologies, Lumenis, and iCare. Shareholder: Johnson & Johnson, LENZ Therapeutics, and Tracey Technologies.
Taylor Strange, DO has a financial agreement or affiliation with the following ineligible companies in the form of Consultant and Speaker’s Bureau: Rxsight, Oculus, Alcon, Johnson & Johnson, BVI, LENSAR, and Carl Zeiss Meditec. Shareholder: RxSight
Tom Harvey, MD has a financial agreement or affiliation with the following ineligible companies in the form of Consultant: Dompé, LENSAR, Lenstec, Topcon, and Carl Zeiss Meditec. Shareholder: Lumos Diagnostics and RPS.
Wade Tucker, MD has no financial relationships with ineligible companies
William Soscia, MD has a financial agreement or affiliation with the following ineligible companies in the form of Consultant: Johnson & Johnson, RxSight and Lensar. Grant/Research Support: Symfony/Synergy
Zahra Markatia, MD has a financial agreement or affiliation with the following ineligible companies in the form of Consultant: Johnson & Johnson
Zarmeena Vendal, MD has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant and Speaker’s Bureau: Alcon, Bausch + Lomb, Biotissue, Johnson & Johnson, Ocular Therapeutix, and Sight Sciences.
